Prometheus Laboratories Inc.
Records under this name other than the patents Prometheus Laboratories Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Back to Prometheus Laboratories Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,582,282 | Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics Formerly held In force · High confidence | In force | High confidence | |
| US 7,695,908 | Methods for Predicting Methotrexate Polyglutamate Levels Using Pharmacogenetics Formerly held In force · High confidence | In force | High confidence | |
| US 7,943,328 | Method and System for Assisting in Diagnosing Irritable Bowel Syndrome Formerly held In force · High confidence | In force | High confidence | |
| US 8,114,616 | Methods for Diagnosing Irritable Bowel Syndrome Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,482,672 | Methods for Diagnosing Irritable Bowel Syndrome Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,127,591 | Engine Supercharger Drive Device Formerly held In force · High confidence | In force | High confidence | |
| US 11,162,943 | Methods for assessing mucosal healing in Crohn's disease patients Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,036,757 | Addressable Antibody Arrays and Methods of Use Lapsed on the fee record Ended Jul 31, 2026 · Low confidence | Lapsed on the fee record | Ended Jul 31, 2026 | Low confidence |
| US 7,670,764 | Methods of Diagnosing Tissue Fibrosis Term ended Term ended May 6, 2026 · High confidence | Term ended | Term ended May 6, 2026 | High confidence |
| US 8,709,733 | Methods for Diagnosing Irritable Bowel Syndrome Formerly held Lapsed on the fee record Ended Apr 29, 2026 · Medium confidence | Lapsed on the fee record | Ended Apr 29, 2026 | Medium confidence |